Both in R&D — Physical & Biological Sciences
Incyte Genomics vs OmniAb
Over the past year INCY returned +11.6% and OABI returned +238.9%; their daily moves had a correlation of 0.18.
INCY +11.6% OABI +238.9%Growth of $1, one year, split-adjusted
| Metric | INCY | OABI |
|---|---|---|
| Price | $118.01 | $4.83 |
| Market cap | $24.05B | $704.5M |
| Today | −3.94% | −6.76% |
| 1 month | +4.0% | +5.9% |
| 6 months | +20.7% | +228.6% |
| Year to date | +19.5% | +161.1% |
| 1 year | +14.7% | +226.4% |
| Revenue growth (YoY) | +14.0% | +78.3% |
| Gross margin | 93.0% | 92.3% |
| Net margin | −50.4% | −393.9% |
| P/E (TTM) | 59.6× | — |
| Price / sales | 4.0× | 17.5× |
| Net cash | $3.82B | $64.2M |
| Dividend yield | — | — |
| Volatility (60d) | 29.8% | 73.3% |
| Short % of float | 5.9% | 9.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).